Skip to main content

Want a detailed portfolio tracker?

INmune Bio (INMB) P/E (2019 - 2026)

INmune Bio (INMB) P/E from Feb 4, 2019 to Jul 21, 2026. The TTM INmune Bio (INMB) P/E is -1.26. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of INmune Bio (INMB)

YearP/EChange
2026-1.26+44.14%
2025-0.87-61.33%
2024-2.26-69.34%
2023-7.37+101.92%
2022-3.65-35.00%
2021-5.61-68.23%
2020-17.67+122.98%
2019-7.92N/A

Comparison INmune Bio (INMB) P/E with competitors

INmune Bio (INMB) P/E is -1.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.34%
ENLVEnlivex Ltd0.07-105.94%
FGENFibroGen Inc0.24-119.07%
CHRSCoherus Biosciences Inc0.85-167.40%
FBIOFortress Biotech Inc0.95-175.38%
ORMPOramed Pharmaceuticals Inc1.50-219.38%
AGENAgenus Inc3.01-339.05%
INVAInnoviva Inc3.15-350.52%
VXRTVaxart Inc3.55-381.95%
CRMDCorMedix Inc3.63-388.20%
CVACCureVac N.V.4.45-453.11%
GLPGGalapagos NV4.86-485.93%
SRPTSarepta Therapeutics Inc4.88-487.77%
ABEOAbeona Therapeutics Inc5.39-527.91%
ABUSArbutus Biopharma Corp5.60-544.44%
ZVRAZevra Therapeutics Inc5.89-567.61%
SPROSpero Therapeutics Inc6.23-594.71%
CGENCompugen Ltd6.31-601.50%
RIGLRigel Pharmaceuticals6.87-645.83%
SLXNSilexion Therapeutics Corp7.30-679.51%
OMEROmeros Corporation9.26-835.40%
AUPHAurinia Pharmaceuticals Inc9.58-861.31%
PLXProtalix BioTherapeutics Inc10.89-965.04%
ACADAcadia Pharmaceuticals Inc11.73-1031.57%
TBPHTheravance Biopharma Inc12.26-1073.95%
ADMAAdma Biologics Inc12.42-1086.34%
HRMYHarmony Biosciences Holdings Inc13.82-1197.70%
SABSSAB Biotherapeutics Inc14.14-1222.80%
NAGENiagen Bioscience Inc14.82-1276.97%
REGNRegeneron Pharmaceuticals Inc15.86-1359.45%
PBYIPuma Biotechnology Inc17.32-1475.34%
CPRXCatalyst Pharmaceuticals Inc17.44-1485.16%
EXELExelixis Inc17.54-1493.00%
TGTXTG Therapeutics Inc18.97-1606.43%
MDXGMimedx Group Inc20.55-1732.44%
XOMAXOMA Royalty Corp22.87-1916.93%
ARGXArgen X SE24.30-2029.98%
CTMXCytomX Therapeutics Inc24.82-2071.53%
XOMAOXOMA Royalty Corp25.34-2113.13%
HALOHalozyme Therapeutics Inc25.62-2135.28%
XOMAPXOMA Royalty Corp25.67-2138.97%
VRTXVertex Pharmaceuticals Inc27.99-2323.61%
RPRXRoyalty Pharma plc - Class A28.69-2378.64%
SLNOSoleno Therapeutics Inc29.02-2404.68%
ASNDAscendis Pharma A/S30.09-2489.68%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3111.34%
APLSApellis Pharmaceuticals Inc39.02-3199.44%
BMRNBiomarin Pharmaceutical Inc42.21-3452.87%
KRYSKrystal Biotech Inc45.34-3701.62%
ONCBeiGene Ltd69.54-5623.58%
PHARPharming Group N.V.75.03-6059.26%
TECHBio-Techne Corp101.96-8198.52%
VCELVericel Corp109.92-8831.02%
ALNYAlnylam Pharmaceuticals Inc117.96-9469.93%
GMABGenmab140.29-11243.25%
TLXTelix Pharmaceuticals Ltd162.15-12979.75%
CORTCorcept Therapeutics Inc212.86-17007.21%